| ¿µ¹® | agonist | ÇÑ±Û | ÀÛ¿ëÁ¦, ÀÛ¿ë±Ù |
|---|---|---|---|
| ¼³¸í | 1. ¼ö¿ëü¿Í °áÇÕÇÏ¿© ÃÖ´ëÀÇ ¾à¸®ÀÛ¿ëÀ» ¹ßÇöÇÏ´Â ÈÇй°ÁúÀ» ¸»ÇÑ´Ù. ¼ö¿ëü¿¡ ƯÀÌÇÏ°Ô Ä£È¼ºÀ» °¡Áö°í ÀÖ´Ù. »ýü ¾È¿¡¼ »ý»êµÇ´Â ³»ÀμºÀÎ °Í°ú »ýü ¹Û¿¡¼ Åõ¿©µÇ´Â ¿ÜÀμºÀÎ °ÍÀÌ ÀÖ´Ù. ºÎºÐ ÀÛ¿ëÁ¦´Â ¼ö¿ëü¿Í °áÇÕÇØµµ 100%ÀÇ ¾à¸®ÀÛ¿ëÀ» ¹ßÇöÇÏÁö´Â ¾ÊÀ¸¸ç ¿ë·®À» Áõ°¡½ÃÄѵµ È¿°ú´Â Ä¿ÁöÁö ¾Ê´Â´Ù. 2. ÇØºÎÇп¡¼´Â ÁÖ°¡ µÇ¾î ¿òÁ÷ÀÌ´Â ±ÙÀ°ÀÇ ¹«¸® |
||
| PAA | partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas... |
|---|---|
| PR | by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr... |
| IHSS(= HCMP) | Idiopathic Hypertrophic Subaortic Stenosis = Obstructive Idiopathic Hypertrophic Car... |
| ORA | opiate receptor agonist |
| PaO2 | partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood |
| R,S | receptor agonist |
|---|---|
| 8-OH-DPAT | 5-HT agonist 8-hydroxy-2-(di-n-propylamino) tetralin |
| 8-OH-DPAT | 5-HT(1A) receptor agonist, 8-hydroxy 2(di-n-propyl(amino)tetralin |
| (35)S | Agonist-stimulated |
| GNRH-a | GnRH agonist |
| opioid partial agonist | <pharmacology> A compound that has an affinity for and stimulates physiologic activity at the same cell receptors as opioid agonists but that produces only a partial (i.e., submaximal) bodily response. (16 Dec 1997) |
|---|---|
| agonist | 1. <anatomy> A prime mover. 2. <pharmacology> A drug that has affinity for and stimulates physiologic activity at cell receptors normally stimulated by naturally occurring substances, thus triggering a biochemical response. (18 Nov 1997) |
| calcium channel agonist | <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (12 Dec 1998) |
| receptor agonist | A substance that mimics a specificneurotransmitter, is able to attach to that neurotransmitter's receptor and thereby produces the same action that theneurotransmitter usually produces. Drugs are often designed as receptor agonists to treat a variety of diseases and disorders whenthe original chemical substance is missing or depleted. (22 May 1997) |
| mixed opioid agonist-antagonist | <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type. (13 Nov 1997) |
| muscarinic agonist | Drugs that bind to and activate muscarinic cholinergic receptors (receptors, muscarinic). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (12 Dec 1998) |
| histamine agonist | Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (12 Dec 1998) |
| opioid agonist | <pharmacology> Any morphine-like compound that produces bodily effects including pain relief, sedation, constipation and respiratory depression. (16 Dec 1997) |
| LH and RH agonist | <pharmacology> Particular medications that act as potent inhibitors of gonadotrophin (testosterone) secretion. They act to inhibit the production of testosterone through a feedback mechanism on the pituitary gland. LH and RH agonists are useful in the treatment of prostate cancer. (14 Oct 1997) |
| activated partial thromboplastin time | The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system. (05 Mar 2000) |
| reaction of partial identity | See: gel diffusion precipitin tests in two dimensions. (05 Mar 2000) |
| partial | 1. Of, pertaining to, or affecting, a part only; not general or universal; not total or entire; as, a partial eclipse of the moon. "Partial dissolutions of the earth." 2. Inclined to favor one party in a cause, or one side of a question, more then the other; baised; not indifferent; as, a judge should not be partial. "Ye have been partial in the law." (Mal. Ii. 9) 3. Having a predelection for; inclined to favor unreasonably; foolishly fond. "A partial parent." "Not partial to an ostentatious display." (Sir W. Scott) 4. <botany> Pertaining to a subordinate portion; as, a compound umbel is made up of a several partial umbels; a leaflet is often supported by a partial petiole. Partial differentials, Partial differential coefficients, Partial differentiation, etc. (of a function of two or more variables), the differentials, differential coefficients, differentiation etc, of the function, upon the hypothesis that some of the variables are for the time constant. <mathematics> Partial fractions, the simple tones which in combination form an ordinary tone; the overtones, or harmonics, which, blending with a fundamental tone, cause its special quality of sound, or timbre, or tone colour. See, also, Tone. Origin: F, fr. LL. Partials, fr. L. Pars, gen. Partis, a part; cf. (for sense 1) F. Partiel. See Part. Source: Websters Dictionary (01 Mar 1998) |
| partial adrenocortical insufficiency | Normal basal adrenocortical function with failure of adrenocortical reserve to respond to ACTH stimulation. (05 Mar 2000) |
| partial agglutinin | Immune agglutinin present in an antiserum in lesser concentration than the major agglutinin. Synonym: partial agglutinin. (05 Mar 2000) |
| partial anencephaly | Congenital failure of the cerebrum to develop normally; usually the cerebellum and basal ganglia are represented at least in rudimentary form. Synonym: partial anencephaly. Origin: hemi-+ G. Kephale, head (05 Mar 2000) |
| partial agonist a. |
intrinsic sympathomimetic a.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|